nach oben

Erschienen in:

02.03.2020 | Original Paper

Infectious mononucleosis, immune genotypes, and non-Hodgkin lymphoma (NHL): an InterLymph Consortium study

verfasst von: Niquelle Brown Wadé, Cindy M. Chang, David Conti, Joshua Millstein, Christine Skibola, Alexandra Nieters, Sophia S. Wang, Silvia De Sanjose, Eleanor Kane, John J. Spinelli, Paige Bracci, Yawei Zhang, Susan Slager, Jun Wang, Henrik Hjalgrim, Karin Ekstrom Smedby, Elizabeth E. Brown, Ruth F. Jarrett, Wendy Cozen, for the InterLymph Consortium Immunology and Infection Working

Erschienen in: Cancer Causes & Control | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We explored the interaction between non-Hodgkin lymphoma (NHL), infectious mononucleosis (IM) history, and immune-related genotypes in a pooled case–control analysis.

Methods

A total of 7,926 NHL patients and 10,018 controls from 12 case–control studies were included. Studies were conducted during various time periods between 1988 and 2008, and participants were 17–96 years of age at the time of ascertainment/recruitment. Self-reported IM history and immune response genotypes were provided by the InterLymph Data Coordinating Center at Mayo Clinic. Odds ratios (OR) were estimated using multivariate logistic regression, and interactions were estimated using the empirical Bayes method. P_ACT was used to account for multiple comparisons.

Results

There was evidence of an interaction effect between IM history and two variants on T-cell lymphoma (TCL) risk: rs1143627 in interleukin-1B (IL1B) (p_interaction = 0.04, OR_interaction = 0.09, 95% confidence interval [CI] 0.01, 0.87) and rs1800797 in interleukin-6 (IL6) (p_interaction = 0.03, OR_interaction = 0.08, 95% CI 0.01, 0.80). Neither interaction effect withstood adjustment for multiple comparisons. There were no statistically significant interactions between immune response genotypes and IM on other NHL subtypes.

Conclusions

Genetic risk variants in IL1B and IL6 may affect the association between IM and TCL, possibly by influencing T-cell activation, growth, and differentiation in the presence of IM, thereby decreasing risk of immune cell proliferation.

Nur mit Berechtigung zugänglich

Morton LM, Sampson JN, Cerhan JR, Turner JJ, Vajdic CM, Wang SS, Smedby KE, De Sanjosé S, Monnereau A, Benavente Y, Bracci PM, Chiu BCH, Skibola CF, Zhang Y, Mbulaiteye SM, Spriggs M, Robinson D, Norman AD, Kane EV, Spinelli JJ, Kelly JL, La Vecchia C, Maso LD, Maynadié M, Kadin ME, Cocco P, Costantini AS, Clarke CA, Roman E, Miligi L, Colt JS, Berndt SI, Mannetje A, de Roos AJ, Kricker A, Nieters A, Franceschi S, Melbye M, Boffetta P, Clavel J, Linet MS, Weisenburger DD, Slager SL (2014) Rationale and design of the international lymphoma epidemiology consortium (interlymph) non-Hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr 2014:1–14. https://doi.org/10.1093/jncimonographs/lgu005 CrossRefPubMedPubMedCentral

Grulich AE, Vajdic CM, Cozen W (2007) Altered immunity as a risk factor for non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 16:405–409CrossRefPubMed

Morton LM, Wang SS, Cozen W, Linet MS, Chatterjee N, Davis S, Severson RK, Colt JS, Vasef MA, Rothman N, Blair A, Bernstein L, Cross AJ, De Roos AJ, Engels E a., Hein DW, Hill D a., Kelemen LE, Lim U, Lynch CF, Schenk M, Wacholder S, Ward MH, Zahm SH, Chanock SJ, Cerhan JR, Hartge P (2008) Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood 112:5150–5160. https://doi.org/10.1182/blood-2008-01-133587

Smedby KE, Vajdic CM, Falster M, Engels EA, Martinez-Maza O, Turner J, Hjalgrim H, Vineis P, Costantini AS, Bracci PM, Holly EA, Willett E, Spinelli JJ, La VC, Zheng T, Becker N, De Sanjosé S, Chiu BCH, Maso LD, Cocco P, Maynadie M, Foretova L, Staines A, Brennan P, Davis S, Severson R, Cerhan JR, Breen EC, Birmann B, Grulich AE, Cozen W (2008) Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 111:4029–4038. https://doi.org/10.1182/blood-2007-10-119974 CrossRef

Cozen W, Cerhan JR, Martinez-Maza O, Ward MH, Linet M, Colt JS, Davis S, Severson RK, Hartge P, Bernstein L (2007) The effect of atopy, childhood crowding, and other immune-related factors on non-Hodgkin lymphoma risk. Cancer Causes Control 18:821–831. https://doi.org/10.1007/s10552-007-9025-5 CrossRefPubMed

Goldin LR, Björkholm M, Kristinsson SY, Turesson I, Landgren O (2009) Highly increased familial risks for specific lymphoma subtypes. Br J Haematol 146:91–94. https://doi.org/10.1111/j.1365-2141.2009.07721.x CrossRefPubMedPubMedCentral

Wang SS, Flowers CR, Kadin ME, Chang ET, Hughes AM, Ansell SM, Feldman AL, Lightfoot T, Boffetta P, Melbye M, Lan Q, Sampson JN, Morton LM, Zhang Y, Weisenburger DD (2014) Medical history, lifestyle, family history, and occupational risk factors for peripheral T-cell lymphomas: The interlymph non-hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr 2014:66–75. https://doi.org/10.1093/jncimonographs/lgu012 CrossRefPubMedPubMedCentral

Hosgood HD, Purdue MP, Wang SS, Zheng T, Morton LM, Lan Q, Menashe I, Zhang Y, Cerhan JR, Grulich A, Cozen W, Yeager M, Holford TR, Vajdic CM, Davis S, Leaderer B, Kricker A, Schenk M, Zahm SH, Chatterjee N, Chanock SJ, Rothman N, Hartge P, Armstrong B (2011) A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk. Br J Haematol 152:721–726. https://doi.org/10.1111/j.1365-2141.2010.08518.x CrossRefPubMedPubMedCentral

Skibola CF, Akers NK, Conde L, Ladner M, Hawbecker SK, Cohen F, Ribas F, Erlich HA, Goodridge D, Trachtenberg EA, Smith MT, Bracci PM (2012) Multi-locus HLA class I and II allele and haplotype associations with follicular lymphoma. Tissue Antigens 79:279–286. https://doi.org/10.1111/j.1399-0039.2012.01845.x CrossRefPubMedPubMedCentral

10.

Wang SS, Abdou AM, Morton LM, Thomas R, Cerhan JR, Gao X, Cozen W, Rothman N, Davis S, Severson RK, Bernstein L, Hartge P, Carrington M (2010) Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology. Blood 115:4820–4823. https://doi.org/10.1182/blood-2010-01-266775 CrossRefPubMedPubMedCentral

11.

Thorley-Lawson DA, Gross A (2004) Persistence of the Epstein–Barr virus and the origins of associated lymphomas. N Engl J Med 350:1328–1337. https://doi.org/10.1056/NEJMra032015 CrossRefPubMed

12.

Ferri C, Caracciolo F, Zignego AL, La CL, Monti M, Longombardo G, Lombardini F, Greco F, Capochiani E, Mazzoni A, Mazzaro C, Pasero G (1994) Hepatitis C virus infection in patients with non-Hodgkin’s lymphoma. Br J Haematol 88:392–394. https://doi.org/10.1111/j.1365-2141.1994.tb05036.x CrossRefPubMed

13.

Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orentreich N, Vogelman JH, Friedman GD (1994) Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330:1267–1271. https://doi.org/10.1056/NEJM199405053301803 CrossRefPubMed

14.

Engels EA (2007) Infectious agents as causes of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 16:401–404. https://doi.org/10.1158/1055-9965.EPI-06-1056 CrossRefPubMed

15.

Longnecker RM, Kieff E, Cohen JI (2013) Epstein-Barr virus. In: Knipe DM, Howley PM (eds) Fields virology, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1898–1959

16.

Fleisher G, Henle W, Henle G, Lennette ET, Biggar RJ (1979) Primary infection with Epstein-Barr virus in infants in the United States: clinical and serologic observations. J Infect Dis 139:553–558. https://doi.org/10.2307/30111515 CrossRefPubMed

17.

Luzuriaga K, Sullivan JL (2010) Infectious mononucleosis. N Engl J Med 362:1993–2000. https://doi.org/10.1056/NEJMcp1001116 CrossRefPubMed

18.

Macsween KF, Johannessen I (2014) Epstein-Barr Virus (EBV): Infectious Mononucleosis and other non-malignant EBV-associated diseases. In: Kaslow RA, Stanberry LR, Duc JW (eds) Viral infections of humans: epidemiology and control. Springer, Boston, pp 867–896CrossRef

19.

Balfour HH, Dunmire SK, Hogquist KA (2015) Infectious mononucleosis. Clin Transl Immunol 4(e33):1–7. https://doi.org/10.1038/cti.2015.1 CrossRef

20.

Callan MFC, Steven N, Krausa P, Wilson JDK, Moss PAH, Gillespie GM, Bell JI, Rickinson AB, Mcmichael AJ (1996) Large clonal expansions of CD8+ T cells in acute infectious mononucleosis. Nat Med 2:906–911CrossRefPubMed

21.

Long HM, Meckiff BJ, Taylor GS (2019) The T-cell response to Epstein-Barr virus—new tricks from an old dog. Front Immunol 10(2193):1–11. https://doi.org/10.3389/fimmu.2019.02193 CrossRef

22.

Jayasooriya S, de Silva TI, Njie-jobe J, Sanyang C, Leese AM, Bell AI, McAulay KA, Yanchun P, Long HM, Dong T, Whittle HC, Rickinson AB, Rowland-Jones SL, Hislop AD, Flanagan KL (2015) Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African children. PLOS Pathog 11:e1004746. https://doi.org/10.1371/journal.ppat.1004746 CrossRefPubMedPubMedCentral

23.

Tian C, Hromatka BS, Kiefer AK, Eriksson N, Noble SM, Tung JY, Hinds DA (2017) Genome-wide association and HLA region fine-mapping studies identify susceptibility loci for multiple common infections. Nat Commun 8(599):1–13. https://doi.org/10.1038/s41467-017-00257-5 CrossRef

24.

McAulay KA, Higgins CD, Macsween KF, Lake A, Jarrett RF, Robertson FL, Williams H, Crawford DH (2007) HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection. J Clin Invest 117:3042–3048. https://doi.org/10.1172/JCI32377.3042 CrossRefPubMedPubMedCentral

25.

Becker N, Falster MO, Vajdic CM, De Sanjose S, Martínez-Maza O, Bracci PM, Melbye M, Smedby KE, Engels EA, Turner J, Vineis P, Costantini AS, Holly EA, Spinelli JJ, La Vecchia C, Zheng T, Chiu BCH, Montella M, Cocco P, Maynadié M, Foretova L, Staines A, Brennan P, Davis S, Severson R, Cerhan JR, Breen EC, Birmann B, Cozen W, Grulich AE, Newton R (2012) Self-reported history of infections and the risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Int J Cancer 131:2342–2348. https://doi.org/10.1002/ijc.27438

26.

Hwang AE, Hamilton AS, Cockburn MG, Ambinder R, Zadnick J, Brown EE, Mack TM, Cozen W (2012) Evidence of genetic susceptibility to infectious mononucleosis: a twin study. Epidemiol Infect 140:2089–2095. https://doi.org/10.1017/S0950268811002457 CrossRefPubMed

27.

Rostgaard K, Wohlfahrt J, Hjalgrim H (2014) A genetic basis for infectious mononucleosis: evidence from a family study of hospitalized cases in Denmark. Clin Infect Dis 58:1684–1689. https://doi.org/10.1093/cid/ciu204 CrossRefPubMed

28.

Kane E, Skibola CF, Bracci PM, Cerhan JR, Costas L, Smedby KE, Holly EA, Maynadié M, Novak AJ, Lightfoot TJ, Ansell SM, Smith AG, Liebow M, Melbye M, Morton L, de Sanjosé S, Slager SL, Wang SS, Zhang Y, Zheng T, Roman E (2015) Non-Hodgkin lymphoma, body mass index, and cytokine polymorphisms: a pooled analysis from the InterLymph Consortium. Cancer Epidemiol Biomarkers Prev 24:1061–1070. https://doi.org/10.1158/1055-9965.EPI-14-1355 CrossRefPubMedPubMedCentral

29.

Skibola CF, Bracci PM, Nieters A, Brooks-Wilson A, de Sanjosé S, Hughes AM, Cerhan JR, Skibola DR, Purdue M, Kane E, Lan Q, Foretova L, Schenk M, Spinelli JJ, Slager SL, De Roos AJ, Smith MT, Roman E, Cozen W, Boffetta P, Kricker A, Zheng T, Lightfoot T, Cocco P, Benavente Y, Zhang Y, Hartge P, Linet MS, Becker N, Brennan P, Zhang L, Armstrong B, Smith A, Shiao R, Novak AJ, Maynadie M, Chanock SJ, Staines A, Holford TR, Holly EA, Rothman N, Wang SS (2010) Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol 171:267–276. https://doi.org/10.1093/aje/kwp383 CrossRefPubMedPubMedCentral

30.

Rothman N, Skibola CF, Wang SS, Morgan G, Lan Q, Smith MT, Spinelli JJ, Willett E, De Sanjose S, Cocco P, Berndt SI, Brennan P, Brooks-Wilson A, Wacholder S, Becker N, Hartge P, Zheng T, Roman E, Holly EA, Boffetta P, Armstrong B, Cozen W, Linet M, Bosch FX, Ennas MG, Holford TR, Gallagher RP, Rollinson S, Bracci PM, Cerhan JR, Whitby D, Moore PS, Leaderer B, Lai A, Spink C, Davis S, Bosch R, Scarpa A, Zhang Y, Severson RK, Yeager M, Chanock S, Nieters A (2006) Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol 7:27–38. https://doi.org/10.1016/S1470-2045(05)70434-4 CrossRefPubMed

31.

Cerhan JR, Ansell SM, Fredericksen ZS, Kay NE, Liebow M, Call TG, Dogan A, Cunningham JM, Wang AH, Liu-Mares W, Macon WR, Jelinek D, Witzig TE, Habermann TM, Slager SL (2007) Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. Blood 110:4455–4463. https://doi.org/10.1182/blood-2007-05-088682 CrossRefPubMedPubMedCentral

32.

Cerhan JR, Fredericksen ZS, Novak AJ, Ansell SM, Kay NE, Liebow M, Dogan A, Cunningham JM, Wang AH, Witzig TE, Habermann TM, Asmann YW, Slager SL (2012) A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region. Cancer Epidemiol Biomarkers Prev 21:1799–1806. https://doi.org/10.1158/1055-9965.EPI-12-0696 CrossRefPubMedPubMedCentral

33.

Conde L, Halperin E, Akers NK, Brown KM, Smedby KE, Rothman N, Nieters A, Slager SL, Brooks-Wilson A, Agana L, Riby J, Liu J, Adami H-O, Darabi H, Hjalgrim H, Low H-Q, Humphreys K, Melbye M, Chang ET, Glimelius B, Cozen W, Davis S, Hartge P, Morton LM, Schenk M, Wang SS, Armstrong B, Kricker A, Milliken S, Purdue MP, Vajdic CM, Boyle P, Lan Q, Zahm SH, Zhang Y, Zheng T, Becker N, Benavente Y, Boffetta P, Brennan P, Butterbach K, Cocco P, Foretova L, Maynadié M, de Sanjosé S, Staines A, Spinelli JJ, Achenbach SJ, Call TG, Camp NJ, Glenn M, Caporaso NE, Cerhan JR, Cunningham JM, Goldin LR, Hanson CA, Kay NE, Lanasa MC, Leis JF, Marti GE, Rabe KG, Rassenti LZ, Spector LG, Strom SS, Vachon CM, Weinberg JB, Holly EA, Chanock S, Smith MT, Bracci PM, Skibola CF (2010) Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet 42:661–664. https://doi.org/10.1038/ng.626 CrossRefPubMedPubMedCentral

34.

Spinelli JJ, Ng CH, Weber J-P, Connors JM, Gascoyne RD, Lai AS, Brooks-Wilson AR, Le ND, Berry BR, Gallagher RP (2007) Organochlorines and risk of non-Hodgkin lymphoma. Int J Cancer 121:2767–2775. https://doi.org/10.1002/ijc.23005 CrossRefPubMed

35.

Besson H, Brennan P, Becker N, Nieters A, De Sanjosé S, Font R, Maynadié M, Foretova L, Cocco PL, Staines A, Vornanen M, Boffetta P (2006) Tobacco smoking, alcohol drinking and non-Hodgkin’s lymphoma: A European multicenter case-control study (Epilymph). Int J Cancer 119:901–908. https://doi.org/10.1002/ijc.21913 CrossRefPubMed

36.

Becker N, Fortuny J, Alvaro T, Nieters A, Maynadié M, Foretova L, Staines A, Brennan P, Boffetta P, Cocco PL, De Sanjose S (2009) Medical history and risk of lymphoma: Results of a European case-control study (EPILYMPH). J Cancer Res Clin Oncol 135:1099–1107. https://doi.org/10.1007/s00432-009-0551-2 CrossRefPubMed

37.

Cerhan JR, Fredericksen ZS, Wang AH, Habermann TM, Kay NE, Macon WR, Cunningham JM, Shanafelt TD, Ansell SM, Call TG, Witzig TE, Slager SL, Liebow M (2011) Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphoma. Int J Mol Epidemiol Genet 2:95–113PubMedPubMedCentral

38.

Chatterjee N, Hartge P, Cerhan JR, Cozen W, Davis S, Ishibe N, Colt J, Goldin L, Severson RK (2004) Risk of non-Hodgkin’s lymphoma and family history of lymphatic, hematologic, and other cancers. Cancer Epidemiol Biomarkers Prev 13:1415–1421PubMed

39.

Hughes AM, Armstrong BK, Vajdic CM, Turner J, Grulich AE, Fritschi L, Milliken S, Kaldor J, Benke G, Kricker A (2004) Sun exposure may protect against non-Hodgkin lymphoma: a case-control study. Int J Cancer 112:865–871. https://doi.org/10.1002/ijc.20470 CrossRefPubMed

40.

Smedby KE, Hjalgrim H, Melbye M, Torrång A, Rostgaard K, Munksgaard L, Adami J, Hansen M, Porwit-MacDonald A, Jensen BA, Roos G, Pedersen BB, Sundström C, Glimelius B, Adami H-O (2005) Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 97:199–209. https://doi.org/10.1093/jnci/dji022 CrossRefPubMed

41.

Holly EA, Lele C, Bracci PM, McGrath MS (1999) Case-control study of non-Hodgkin’s lymphoma among women and heterosexual men in the San Francisco Bay Area, California. Am J Epidemiol 150:375–389CrossRefPubMed

42.

Holly EA, Bracci PM (2003) Population-based study of non-Hodgkin lymphoma, histology, and medical history among human immunodeficiency virus-negative participants in San Francisco. Am J Epidemiol 158:316–327CrossRefPubMed

43.

Morton LM, Holford TR, Leaderer B, Zhang Y, Zahm SH, Boyle P, Flynn S, Tallini G, Owens PH, Zhang B, Zheng T (2003) Alcohol use and risk of non-Hodgkin’s lymphoma among Connecticut women (United States). Cancer Causes Control 14:687–694. https://doi.org/10.1023/A:1025626208861 CrossRefPubMed

44.

Smedby KE, Foo JN, Skibola CF, Darabi H, Conde L, Hjalgrim H, Kumar V, Chang ET, Rothman N, Cerhan JR, Brooks-Wilson AR, Rehnberg E, Irwan ID, Ryder LP, Brown PN, Bracci PM, Agana L, Riby J, Cozen W, Davis S, Hartge P, Morton LM, Severson RK, Wang SS, Slager SL, Fredericksen ZS, Novak AJ, Kay NE, Habermann TM, Armstrong B, Kricker A, Milliken S, Purdue MP, Vajdic CM, Boyle P, Lan Q, Zahm SH, Zhang Y, Zheng T, Leach S, Spinelli JJ, Smith MT, Chanock SJ, Padyukov L, Alfredsson L, Klareskog L, Glimelius B, Melbye M, Liu ET, Adami HO, Humphreys K, Liu J (2011) GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma. PLoS Genet 7:e1001378. https://doi.org/10.1371/journal.pgen.1001378

45.

Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, Jack A, Cozen W, Maynadié M, Spinelli JJ, Costantini AS, Rüdiger T, Scarpa A, Zheng T, Weisenburger DD (2007) Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 110:695–708. https://doi.org/10.1182/blood-2006-11-051672 CrossRefPubMedPubMedCentral

46.

Turner JJ, Morton LM, Linet MS, Clarke CA, Kadin ME, Vajdic CM, Monnereau A, Maynadiè M, Chiu BCH, Marcos-Gragera R, Costantini AS, Cerhan JR, Weisenburger DD (2010) InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): Update and future directions. Blood 116:e90–398CrossRefPubMedPubMedCentral

47.

Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman J (2008) WHO Classification of tumours of haematopoietic and lymphoid tissues, 4th edn. International Agency for Research on Cancer, Lyon

48.

Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O’Donnell CJ, De Bakker PIW (2008) SNAP: A web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24:2938–2939. https://doi.org/10.1093/bioinformatics/btn564 CrossRefPubMedPubMedCentral

49.

Mukherjee B, Ahn J, Gruber SB, Rennert G, Moreno V, Chatterjee N (2008) Tests for gene–environment interaction from case-control data: a novel study of type I error, power and designs. Genet Epidemiol 32:615–626. https://doi.org/10.1002/gepi.20337 CrossRefPubMed

50.

Conneely KN, Boehnke M (2007) So many correlated tests, so little time! rapid adjustment of p values for multiple correlated tests. Am J Hum Genet 81:1158–1168. https://doi.org/10.1086/522036 CrossRefPubMedPubMedCentral

51.

Pike BL, Nossal GJ (1985) Interleukin 1 can act as a B-cell growth and differentiation factor. Proc Natl Acad Sci U S A 82:8153–8157CrossRefPubMedPubMedCentral

52.

Lichtman AH, Chin J, Schmidt JA, Abbas AK (1988) Role of interleukin 1 in the activation of T lymphocytes. Proc Natl Acad Sci U S A 85:9699–9703CrossRefPubMedPubMedCentral

53.

Schett G, Dayer J-M, Manger B (2016) Interleukin-1 function and role in rheumatic disease. Nat Rev Rheumatol 12:14–24. https://doi.org/10.1038/nrrheum.2016.166 CrossRefPubMed

54.

Nambu A, Nakae S, Iwakura Y (2006) IL-1β, but not IL-1α, is required for antigen-specific T cell activation and the induction of local inflammation in the delayed-type hypersensitivity responses. Int Immunol 18:701–712. https://doi.org/10.1093/intimm/dxl007 CrossRefPubMed

55.

Hackett RJ, Davis LS, Lipsky PE (1988) Comparative effects of tumor necrosis factor-alpha and IL-1 beta on mitogen-induced T cell activation. J Immunol 140:2639–2644PubMed

56.

Hirbod-Mobarakeh A, Amirzargar AA, Nikbin B, Nicknam MH, Kutikhin A, Rezaei N (2015) Immunogenetics of cancer. In: Cancer immunology. Springer, Berlin, pp 295–341

57.

Kasztelewicz B, Jankowska I, Pawłowska J, Teisseyre J, Dzierzanowska-Fangrat K (2012) The impact of cytokine gene polymorphisms on Epstein–Barr virus infection outcome in pediatric liver transplant recipients. J Clin Virol 55:226–232. https://doi.org/10.1016/j.jcv.2012.07.005 CrossRefPubMed

58.

Terry CF, Loukaci V, Green FR (2000) Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 275:18138–18144. https://doi.org/10.1074/jbc.M000379200 CrossRefPubMed

59.

Burger R (2013) Impact of Interleukin-6 in hematological malignancies. Transfus Med Hemother 40:336–343CrossRefPubMedPubMedCentral

60.

Abramson JS, Feldman T, Kroll-Desrosiers AR, Muffly LS, Winer E, Flowers CR, Lansigan F, Nabhan C, Nastoupil LJ, Nath R, Goy A, Castillo JJ, Jagadeesh D, Woda B, Rosen ST, Smith SM, Evens AM (2014) Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy. Ann Oncol 25:2211–2217. https://doi.org/10.1093/annonc/mdu443 CrossRefPubMedPubMedCentral

61.

Coiffier B, Brousse N, Peuchmaur M, Berger F, Gisselbrecht C, Bryon PA, Diebold J (1990) Original article: peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. Ann Oncol 1:45–50. https://doi.org/10.1093/oxfordjournals.annonc.a057673 CrossRefPubMed

62.

Weisenburger DD, Savage KJ, Harris NL, Gascoyne RD, Jaffe ES, MacLennan KA, Rüdiger T, Pileri S, Nakamura S, Nathwani B, Campo E, Berger F, Coiffier B, Kim WS, Holte H, Federico M, Au WY, Tobinai K, Armitage JO, Vose JM (2011) Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. Blood 117:3402–3408. https://doi.org/10.1182/blood-2010-09-310342 CrossRefPubMed

63.

Talpur R, Singh L, Daulat S, Liu P, Seyfer S, Trynosky T, Wei W, Duvic M (2012) Long-term outcomes of 1,263 patients with mycosis fungoides and sézary syndrome from 1982 to 2009. Clin Cancer Res 18:5051–5060. https://doi.org/10.1158/1078-0432.CCR-12-0604 CrossRefPubMed

64.

Houldcroft CJ, Kellam P (2015) Host genetics of Epstein-Barr virus infection, latency and disease. Rev Med Virol 25:71–84CrossRefPubMed

Titel: Infectious mononucleosis, immune genotypes, and non-Hodgkin lymphoma (NHL): an InterLymph Consortium study
verfasst von: Niquelle Brown Wadé
Cindy M. Chang
David Conti
Joshua Millstein
Christine Skibola
Alexandra Nieters
Sophia S. Wang
Silvia De Sanjose
Eleanor Kane
John J. Spinelli
Paige Bracci
Yawei Zhang
Susan Slager
Jun Wang
Henrik Hjalgrim
Karin Ekstrom Smedby
Elizabeth E. Brown
Ruth F. Jarrett
Wendy Cozen
for the InterLymph Consortium Immunology and Infection Working
Publikationsdatum: 02.03.2020
Verlag: Springer International Publishing
Erschienen in: Cancer Causes & Control / Ausgabe 5/2020
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-020-01266-4

Springer Medizin

Infectious mononucleosis, immune genotypes, and non-Hodgkin lymphoma (NHL): an InterLymph Consortium study